Tatva Chintan Pharma Chem consolidated net profit declines 95.95% in the December 2024 quarter
Net profit of Tatva Chintan Pharma Chem declined 95.95% to Rs 0.14 crore in the quarter ended December 2024 as against Rs 3.46 crore during the previous quarter ended December 2023. Sales rose 2.01% to Rs 85.90 crore in the quarter ended December 2024 as against Rs 84.21 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended | ||
Dec. 2024 | Dec. 2023 | % Var. | |
Sales | 85.90 | 84.21 | 2 |
OPM % | 8.22 | 13.05 | - |
PBDT | 6.69 | 11.83 | -43 |
PBT | -0.24 | 5.24 | PL |
NP | 0.14 | 3.46 | -96 |

Why Gold Remains a Safe Haven Amid Global Economic Shifts in 2025
4 mins read . Sep 5, 2025

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025
3 mins read . Aug 20, 2025

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025
8 mins read . Aug 18, 2025

Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •